The 'Dispatched' Week in Review Podcast - 24 April

This is a preview of subscriber content

Subscribe now to continue reading.

Another significant ministerial speech for the health portfolio that highlights the reform challenge and the importance of choices. A review announced in 2021 without an official response, and the reform of a major program announced with enabling legislation to be tabled next month. It's all about choices and priorities. Also, official recognition of discussions about managing a more assertive US on medicines pricing. What does it really mean? …

Subscribe now to continue reading.

The 'Dispatched' Week in Review Podcast - 24 April

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

Invitation confusion clouds Delphi studies and captures medical device sector

Officials confirm shift in Budget management of underspends

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New Stories

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS

Sign In

The 'Dispatched' Week in Review Podcast - 24 April

This is a preview of subscriber content

Latest Video

Most Read

Officials talk down the prospect of MFN impact on the PBS

An exchange that reveals the truth of a review that has now become a lot like 'Weekend at Bernie's'

Invitation confusion clouds Delphi studies and captures medical device sector

Officials confirm shift in Budget management of underspends

A clear disconnect between the public and private on 'Most Favored Nation' pricing

Follow Us

New Stories

Opthea returns to ASX and works to restart eye therapy candidate

A clear disconnect between the public and private on 'Most Favored Nation' pricing

New blueprint charts a potential policy path forward on biosimilars

Officials cite company consultation, system changes, and spending approvals to justify delay

Novo Nordisk's Marie Krogh Prize returns and crosses the Tasman to back early career women in science

Study confirms pharmacist led care expands timely access to urinary tract infection treatment and contraception

Officials talk down the prospect of MFN impact on the PBS